4 active not recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 4 |
Follow Metastatic Lung Small Cell Carcinoma: new trials by email Literature Review of Metastatic Lung Small Cell Carcinoma trials Research Report on Metastatic Lung Small Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 8 | 2021-11-22 | 2026-05-28 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Neoplasm | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 29 | 2021-10-20 | 2026-09-10 |
| Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors Berzosertib, Quality-of-Life Assessment, Therapeutic Conventional Surgery - Metastatic Lung Neuroendocrine Neoplasm, Metastatic Lung Non-Small Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 15 | 2017-05-22 | 2026-10-14 |
| M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Berzosertib, Biopsy Specimen, Biospecimen Collection - Metastatic Colorectal Carcinoma, Metastatic Lung Small Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 66 | 2016-07-22 | 2026-09-25 |
Lung Neoplasms (4) · Small Cell Lung Carcinoma (4) · Neoplasm Metastasis (3) · Carcinoma, Non-Small-Cell Lung (2) · Pancreatic Neoplasms (2) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Medullary (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Colorectal Neoplasms (1) · HIV Infections (1) · Melanoma (1) · Ovarian Neoplasms (1)
Bronchial Neoplasms (4) · Carcinoma, Bronchogenic (4) · Lung Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Thoracic Neoplasms (4) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Neoplastic Processes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Specimen Handling (3) · Irinotecan (2) · Magnetic Resonance Spectroscopy (2) · berzosertib (2) · BAY 1895344 (1) · Biopsy (1) · Nivolumab (1) · Topotecan (1) · cabozantinib (1)
National Cancer Institute (NCI) (4)
United States (4)
Haiying Cheng (1) · Liza C Villaruz (1) · Pranshu Mohindra (1) · Thatcher Heumann (1)
UM1CA186689 (2), UM1CA186690 (2), UM1CA186644 (1), UM1CA186686 (1), UM1CA186691 (1), UM1CA186704 (1), UM1CA186717 (1)